JP2011516521A5 - - Google Patents

Download PDF

Info

Publication number
JP2011516521A5
JP2011516521A5 JP2011503429A JP2011503429A JP2011516521A5 JP 2011516521 A5 JP2011516521 A5 JP 2011516521A5 JP 2011503429 A JP2011503429 A JP 2011503429A JP 2011503429 A JP2011503429 A JP 2011503429A JP 2011516521 A5 JP2011516521 A5 JP 2011516521A5
Authority
JP
Japan
Prior art keywords
allergen
dosage form
solid dosage
administration
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011503429A
Other languages
English (en)
Japanese (ja)
Other versions
JP5618981B2 (ja
JP2011516521A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/054186 external-priority patent/WO2009124954A1/en
Publication of JP2011516521A publication Critical patent/JP2011516521A/ja
Publication of JP2011516521A5 publication Critical patent/JP2011516521A5/ja
Application granted granted Critical
Publication of JP5618981B2 publication Critical patent/JP5618981B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011503429A 2008-04-11 2009-04-08 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法 Expired - Fee Related JP5618981B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4440108P 2008-04-11 2008-04-11
DKPA200800533 2008-04-11
DKPA200800533 2008-04-11
US61/044,401 2008-04-11
PCT/EP2009/054186 WO2009124954A1 (en) 2008-04-11 2009-04-08 Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014187908A Division JP2015013891A (ja) 2008-04-11 2014-09-16 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法

Publications (3)

Publication Number Publication Date
JP2011516521A JP2011516521A (ja) 2011-05-26
JP2011516521A5 true JP2011516521A5 (https=) 2012-05-31
JP5618981B2 JP5618981B2 (ja) 2014-11-05

Family

ID=39809974

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011503429A Expired - Fee Related JP5618981B2 (ja) 2008-04-11 2009-04-08 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法
JP2014187908A Pending JP2015013891A (ja) 2008-04-11 2014-09-16 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014187908A Pending JP2015013891A (ja) 2008-04-11 2014-09-16 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法

Country Status (12)

Country Link
US (2) US9248097B2 (https=)
EP (1) EP2265285B1 (https=)
JP (2) JP5618981B2 (https=)
CN (1) CN102014954A (https=)
AU (1) AU2009235490B2 (https=)
BR (1) BRPI0911433A2 (https=)
CA (1) CA2720455A1 (https=)
DE (1) DE202008006598U1 (https=)
EA (1) EA019202B1 (https=)
ES (1) ES2406391T3 (https=)
MX (1) MX2010011012A (https=)
WO (1) WO2009124954A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US7608693B2 (en) 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
US20120100163A1 (en) * 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
US20120100164A1 (en) 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material
EP2681555B1 (en) 2011-02-25 2020-04-08 Benaroya Research Institute Detection of an allergic disorder
JP2012240975A (ja) * 2011-05-20 2012-12-10 Nitto Denko Corp 医薬組成物及びゼリー状製剤
JP2012240978A (ja) * 2011-05-20 2012-12-10 Nitto Denko Corp 医薬組成物及びゼリー状製剤
US12268718B2 (en) 2012-01-16 2025-04-08 Labyrinth Holdings Llc Control of cellular redox levels
CA3208225A1 (en) 2012-01-16 2013-07-25 Elizabeth Mckenna Compositions and methods for the treatment of hepatitic diseases and disorders
US9574004B2 (en) 2012-08-21 2017-02-21 Sanofi Biotechnology Methods for treating or preventing asthma by administering an IL-4R antagonist
PT3889181T (pt) 2012-09-07 2024-05-29 Regeneron Pharma Um anticorpo antagonista de il-4r para utilização no tratamento da dermatite atópica por administração
JP2015535829A (ja) 2012-09-21 2015-12-17 マッケーナ、エリザベス 天然に存在するCpGオリゴヌクレオチド組成物およびその治療的適用
TWI633891B (zh) 2013-06-04 2018-09-01 再生元醫藥公司 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
TWI682781B (zh) 2013-07-11 2020-01-21 美商再生元醫藥公司 藉由投與il-4r抑制劑治療嗜酸性食道炎的方法
WO2015130975A1 (en) 2014-02-28 2015-09-03 Regeneron Pharmaceuticals, Inc. Methods for treating skin infection by administering an il-4r antagonist
AU2015346150B2 (en) 2014-11-14 2021-08-19 Regeneron Pharmaceuticals, Inc. Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
HUE067888T2 (hu) 2016-09-01 2024-11-28 Regeneron Pharma Módszerek az allergia megelõzésére vagy kezelésére egy IL-4R antagonista adagolásával
WO2018057776A1 (en) 2016-09-22 2018-03-29 Regeneron Pharmaceuticals, Inc. Methods for treating severe atopic dermatitis by administering an il-4r inhibitor
TWI784988B (zh) 2016-12-01 2022-12-01 美商再生元醫藥公司 治療發炎症狀的方法
US11053309B2 (en) 2017-08-04 2021-07-06 Regeneron Pharmaceuticals, Inc. Methods for treating active eosinophilic esophagitis
CA3079946A1 (en) 2017-10-30 2019-05-09 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
US11292847B2 (en) 2018-05-13 2022-04-05 Regeneron Pharmaceuticals, Inc. Methods for treating atopic dermatitis by administering an IL-4R inhibitor
CA3132587A1 (en) 2019-03-21 2020-09-24 Regeneron Pharmaceuticals, Inc. Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy
BR112022000740A2 (pt) 2019-07-16 2022-07-05 Sanofi Biotechnology Métodos para tratamento ou prevenção de asma por administração de um antagonista de il-4r
WO2021026205A1 (en) 2019-08-05 2021-02-11 Regeneron Pharmaceuticals, Inc. Methods for treating atopic dermatitis by administering an il-4r antagonist
US11504426B2 (en) 2019-08-05 2022-11-22 Regeneron Pharmaceuticals, Inc. Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist
EP4513185A1 (en) * 2023-08-22 2025-02-26 Luxembourg Institute of Health (LIH) Early response biomarkers for allergen immunotherapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK137992D0 (da) 1992-11-13 1992-11-13 Alk Lab As Fremgangsmaade til paavisning af et immunologisk aktivt stof i en proeve under anvendelse af et maerkningsstof
JPH0959179A (ja) * 1995-08-28 1997-03-04 Japan Tobacco Inc スギ花粉症予防性を有する口腔衛生剤
PL194804B1 (pl) 1998-03-16 2007-07-31 Alk Abello As Zrekombinowany alergen, sposób przygotowywania zrekombinowanego alergenu, kompozycja farmaceutyczna oraz zastosowanie zrekombinowanego alergenu do przygotowywania leku do wywoływania odpowiedzi immunologicznej u osobnika i do przygotowywania leku do leczenia, zapobiegania lub osłabiania reakcji alergicznych
FR2778244B1 (fr) 1998-04-30 2000-07-13 Univ Joseph Fourier Procede d'excitation d'une cavite optique pour la detection de gaz a l'etat de traces
ATE414773T1 (de) 2000-11-16 2008-12-15 Alk Abello As Mutante allergene
CN1668737A (zh) 2002-05-16 2005-09-14 阿尔克-阿贝洛有限公司 重组Bet.V.1过敏原突变体及其方法和制备
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
CA2554337A1 (en) 2004-02-06 2005-08-25 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
CA2556557A1 (en) * 2004-02-26 2005-09-09 Alk Abello A/S Method of evaluating the therapeutic potential of a vaccine for mucosal administration
US20060115499A1 (en) 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
CN101065146B (zh) * 2004-11-10 2012-11-14 爱尔开-阿贝优公司 通过过敏反应疫苗的粘膜给药预防性治疗过敏反应的方法
WO2006050729A2 (en) 2004-11-10 2006-05-18 Alk-Abellò A/S Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
CN101098711A (zh) * 2005-01-07 2008-01-02 阿尔克-阿贝洛有限公司 通过口粘膜施用变态反应疫苗预防性治疗变态反应的方法
US20060210590A1 (en) * 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
AU2006299310A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
EP1814516B1 (en) 2005-11-04 2012-12-26 Alk-Abelló A/S Use of a liquid allergy vaccine formulation for oromucosal administration
CA2682054A1 (en) * 2007-03-28 2008-10-02 Alk-Abello A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
DE202007004567U1 (de) 2007-03-28 2007-10-11 Alk-Abelló A/S Verwendung einer adjuvierten Allergievakzinformulierung zur parenteralen Verabreichung
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung

Similar Documents

Publication Publication Date Title
JP2011516521A5 (https=)
US20060062835A1 (en) Multi-disciplinary nicotine craving reduction kit with potentiating homeopathic elements
JP2010132695A5 (https=)
JP2012500090A5 (https=)
NZ606548A (en) Dry powder formulation comprising a phosphodiesterase inhibitor
JP2010535805A5 (https=)
MX2009002314A (es) Composiciones farmaceuticas que comprenden hgh para suministro oral.
WO2009142772A3 (en) Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
CN101829036A (zh) 口腔喷雾剂
JP2012236834A5 (https=)
US20160250168A1 (en) Esters of short chains fatty acids for use in the treatment of immunogenic disorders
MX2010013567A (es) Biopolimeros marinos antialergicos.
JP2013523628A5 (https=)
JP2013520448A5 (https=)
WO2010003472A3 (de) Lutschzusammensetzung zur behandlung von entzündlichen erkrankungen des mund- und rachenraums
TW201023869A (en) Antitussive agent and manufacture thereof
WO2012042197A3 (en) Low dose pharmaceutical composition comprising zanamivir
CN1927160A (zh) 漱口液及制备方法
CN103340799B (zh) 金钮扣提取物在制备口腔护理用品中的应用
JP2012097036A5 (https=)
Patil et al. Ethno-pharmacological review of a herbal drug: Anogeissus latifolia
CN103169769A (zh) 一种丁香甘草粉
CN101966190A (zh) 一种治疗高血压含氨氯地平和依普罗沙坦的复方制剂
CN1985923A (zh) 一种防治咽喉疾病的药物组合物及其制备方法
WO2011156822A3 (en) Pharmaceutical compositions